In melanoma, DEK silencing considerably increased cell apoptosis and senescence through DOX treatment and had no effect on TP53 and CDKN2A levels but had a significant effect on CDKN1A and caspase-3 levels [13]. This evidence concerns the gene DEK and melanoma.